Výsledky vyhledávání

Akademický článek

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

Autor: Dong-Jing Fu, Qiaoyi Zhang, Ling Shi, Stephane Borentain, Shien Guo, Maju Mathews, Joana Anjo, Abigail I. Nash, Marguerite O’Hara, Carla M. Canuso

Publikováno v: BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)

Abstract Background Esketamine (ESK) nasal spray, taken with oral antidepressant therapy, is approved for the treatment of depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. In pooled analyses

Externí odkaz: https://doaj.org/article/d92b57827e9447c8beae3bbfa80e1b55

Zobrazit plný text záznamu

Plný text ve formátu HTML

Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorder

Autor: Qiaoyi Zhang, Marguerite O’Hara, Carter McCormick, Melissa Lingohr-Smith, Stephane Borentain, Maju Mathews, Kruti Joshi, Joana Anjo, Jay Lin

Publikováno v: Journal of Medical Economics. 25:172-181

To gain a better understanding of the characteristics of patients with a hospital encounter for major depressive disorder (MDD) and evaluate associated hospital resource utilization, hospital charges and costs, and hospital re-encounters.Adult patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a099267da804e6da0251b53bf856697
https://doi.org/10.1080/13696998.2022.2031202

Zobrazit plný text záznamu

Delphi panel to obtain clinical consensus regarding the importance of rapid reduction in depressive symptoms in patients with major depressive disorder with acute suicidal ideation or behavior (MDSI)

Autor: Stephane Borentain, Carter McCormick, Kruti Joshi, Marguerite O’Hara, Qiaoyi Zhang, Siobhan Mulhern Haughey, Sarah Richards, Joana Anjo, David Zante, Rachel Kewley, Danielle Riley, Nirav Nagda, Richard Perry

Background: Though oral antidepressants can be effective at reducing depressive symptoms, they can take 4–6 weeks to reach full effect. Limitations relating to slow onset of action and resistance to current treatments for patients with major depres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3e596b1ab15ed264111b7662c7b7aa9
https://doi.org/10.21203/rs.3.rs-2138354/v1

Zobrazit plný text záznamu

Treatment patterns and decision drivers to discharge patients with depression hospitalised for acute suicidal ideation in Europe

Autor: Ute Lewitzka, Joana Anjo, Tiina Annus, Stephane Borentain, Kirsty Hope, Andrew Major, Marguerite O'Hara, Maurizio Pompili

Publikováno v: Journal of affective disorders. 311

There is limited published information about the management of patients with major depressive disorder (MDD) hospitalised for acute suicidal ideation (SI). This study aimed to identify treatment patterns and unmet needs in the management of these pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b85f0e4c79ab74a1d8630d50ac8e98be
https://pubmed.ncbi.nlm.nih.gov/35598749

Zobrazit plný text záznamu

Real-World Data on Frontline (FL) Treatments in Multiple Myeloma (MM) Patients across EU5 Countries

Autor: Maren Gaudig, Alex Rider, Joana Anjo, A. Bailey

Publikováno v: Blood. 132:5858-5858

Objective This analysis was conducted to understand the clinical practice on FL treatment in patients with MM across EU5 countries. Methods Real world data were collected through Adelphi's Disease-Specific ProgrammeTM - a point in time survey adminis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40ad6a62861117c24122b3950521faa8
https://doi.org/10.1182/blood-2018-99-113561

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání